First Hawaiian Bank’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-10,815
Closed -$1.42M 876
2022
Q4
$1.42M Sell
10,815
-260
-2% -$33.6K 0.05% 283
2022
Q3
$1.29M Buy
+11,075
New +$1.38M 0.05% 278
2019
Q2
Sell
-1,380
Closed -$154K 1112
2019
Q1
$154K Buy
1,380
+61
+5% +$6.69K 0.01% 803
2018
Q4
$127K Buy
1,319
+1
+0.1% +$106 0.01% 836
2018
Q3
$161K Buy
+1,318
New +$155K 0.01% 824

Other funds holding IBB

First Hawaiian Bank's IBB Position: Q1 2023 in Review

First Hawaiian Bank sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 10,815 shares — an estimated $1.42M sold.

First Hawaiian Bank first reported a position in IBB in Q3 2018 and held it in 5 quarters. The position peaked at $1.42M in Q4 2022. 867 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

  • First Hawaiian Bank reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
  • First Hawaiian Bank sold 10,815 iShares Biotechnology ETF shares in Q1 2023, an estimated $1.42M.
  • First Hawaiian Bank first reported a position in iShares Biotechnology ETF in Q3 2018 and held it in 5 quarters.
  • First Hawaiian Bank's iShares Biotechnology ETF position peaked at $1.42M in Q4 2022.
  • 867 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on First Hawaiian Bank's 13F filing for Q1 2023, filed 18 Apr 2023.